Enlivex Therapeutics Ltd Long-term Investment Intensity
Enlivex Therapeutics Ltd long-term investment intensity. Enlivex Therapeutics Ltd (ENLV) has a Long-term Investment Intensity of 0.0% as of December 2021. Long-term investments of ILA3.00K represent 0.0% of total assets of ILA95.15 Million. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Read Enlivex Therapeutics Ltd debt and liabilities for a breakdown of total debt and financial obligations.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Long-term Investment Intensity of Enlivex Therapeutics Ltd (2021–2021)
Long-term investment intensity of Enlivex Therapeutics Ltd from 2021 to 2021. This chart shows how Enlivex Therapeutics Ltd's Long-term Investment Intensity has evolved across 1 annual periods from 2021 to 2021. As of December 2021, the intensity stands at 0.0%, reflecting long-term investments of ILA3.00K against total assets of ILA95.15 Million ILA.
Enlivex Therapeutics Ltd Long-term Investment Intensity by Year (2021–2021)
Enlivex Therapeutics Ltd long-term investment intensity by year from 2021 to 2021. The table below presents the year-by-year Long-term Investment Intensity for Enlivex Therapeutics Ltd from 2021 to 2021, covering 1 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see Enlivex Therapeutics Ltd asset portfolio.
| Year | LT Investment Intensity | LT Investments (ILA) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2021 | 0.0% | ILA3.00K | ILA95.15 Million | — |